Operating Earnings
Breakdown
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Medical Devices | $1.51B | $1.51B | $1.77B | $1.61B | $1.80B | $1.83B | $1.98B | $1.89B |
| Established Pharmaceuticals | $315.00M | $380.00M | $271.00M | $298.00M | $346.00M | $391.00M | $255.00M | $365.00M |
| Diagnostic Products | $430.00M | $558.00M | $611.00M | $359.00M | $372.00M | $400.00M | $609.00M | $335.00M |
| Nutritional Products | $373.00M | $312.00M | $443.00M | $394.00M | $418.00M | $360.00M | $386.00M | $311.00M |
| Total | $1.67B | $1.86B | $1.91B | $1.69B | $2.05B | $2.06B | $2.25B | $1.35B |
Segments
Established PharmaceuticalsView metric
Nutritional ProductsView metric
Diagnostic ProductsView metric
Medical DevicesView metric